Contact

All Stories

  1. Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  2. Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  3. Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  4. Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  5. Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  6. Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  7. Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  8. Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  9. Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  10. Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  11. Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  12. Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  13. Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  14. Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  15. Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  16. Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  17. Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  18. Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2025, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  19. Future myocardial infarction after an acute coronary syndrome and pharmacogenetic response to dalcetrapib

    Article • European Journal of Preventive Cardiology, October 2025, Oxford University Press (OUP)

    Marie-Pierre Dubé

  20. Genetic analyses across cardiovascular traits: leveraging genetic correlations to empower locus discovery and prediction in common cardiovascular diseases

    Article • npj Genomic Medicine, September 2025, Springer Science + Business Media

    Marie-Pierre Dubé

  21. Impact of clonal hematopoiesis on cardiovascular outcomes in cancer patients of the UK Biobank

    Article • ESMO Open, August 2025, Elsevier

    Marie-Pierre Dubé

  22. Effect of probiotic supplementation on glycemic control in patients with type 2 diabetes: A randomized controlled trial

    Article • Clinical Nutrition ESPEN, August 2025, Elsevier

    Marie-Pierre Dubé

  23. Investigating the effects of a randomized, double-blinded aerobic, resistance, and cognitive training clinical trial on neurocognitive function in older adults with cardiovascular risk factors: the ACTIONcardioRisk protocol

    Article • Frontiers in Aging Neuroscience, June 2025, Frontiers

    Marie-Pierre Dubé

  24. Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis

    Article • European Heart Journal, May 2025, Oxford University Press (OUP)

    Marie-Pierre Dubé

  25. A genome-wide study of the effect of alcohol consumption on the risk of type 2 diabetes

    Article • Clinical Nutrition Open Science, April 2025, Elsevier

    Marie-Pierre Dubé

  26. Disentangling the effects of sex and gender on APOE ɛ4–related neurocognitive impairment

    Article • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, April 2025, Wiley

    Marie-Pierre Dubé

  27. RISK SCORE FOR FUTURE MYOCARDIAL INFARCTION AFTER AN ACUTE CORONARY SYNDROME AND PHARMACOGENETIC RESPONSE TO DALCETRAPIB

    Article • Journal of the American College of Cardiology, April 2025, Elsevier

    Marie-Pierre Dubé

  28. Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes

    Article • Nature Genetics, March 2025, Springer Science + Business Media

    Marie-Pierre Dubé

  29. GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study

    Article • Pharmacological Research, February 2025, Elsevier

    Marie-Pierre Dubé

  30. A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progress

    Article • European Journal of Clinical Pharmacology, December 2024, Springer Science + Business Media

    Marie-Pierre Dubé

  31. Accountability for Reasonableness as a Framework for the Promotion of Fair and Equitable Research

    Article • The Hastings Center Report, December 2024, Wiley

    Marie-Pierre Dubé

  32. Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy

    Article • Nature Genetics, November 2024, Springer Science + Business Media

    Marie-Pierre Dubé

  33. The Relationship Between Perceived Parenting Practices and Anxiety in Adults With Congenital Heart Disease

    Article • Canadian Journal of Cardiology, November 2024, Elsevier

    Marie-Pierre Dubé

  34. The role of genetically predicted serum iron levels on neurodegenerative and cardiovascular traits

    Article • Scientific Reports, October 2024, Springer Science + Business Media

    Marie-Pierre Dubé

  35. Reduction of clonal hematopoiesis mutation burden in coronary patients treated with low-dose colchicine

    Article • October 2024, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  36. Pharmacogenomics of CRP response to statins: a GIST consortium study

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    Marie-Pierre Dubé

  37. Plasma statin concentrations do not correlate with statin-induced myalgia

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    Marie-Pierre Dubé

  38. Data from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  39. Supplementary Figure 1 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  40. Supplementary Figure 1 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  41. Supplementary Figure 2 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  42. Supplementary Figure 2 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  43. Supplementary Table 1 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  44. Supplementary Table 1 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  45. Supplementary Table 10 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  46. Supplementary Table 10 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  47. Supplementary Table 11 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  48. Supplementary Table 11 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  49. Supplementary Table 12 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  50. Supplementary Table 12 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  51. Supplementary Table 13 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  52. Supplementary Table 13 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  53. Supplementary Table 14 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  54. Supplementary Table 14 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  55. Supplementary Table 15 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  56. Supplementary Table 15 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  57. Supplementary Table 16 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  58. Supplementary Table 16 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  59. Supplementary Table 2 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  60. Supplementary Table 2 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  61. Supplementary Table 3 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  62. Supplementary Table 3 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  63. Supplementary Table 4 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  64. Supplementary Table 4 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  65. Supplementary Table 5 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  66. Supplementary Table 5 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  67. Supplementary Table 6 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  68. Supplementary Table 6 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  69. Supplementary Table 7 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  70. Supplementary Table 7 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  71. Supplementary Table 8 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  72. Supplementary Table 8 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  73. Supplementary Table 9 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  74. Supplementary Table 9 from Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors

    Article • September 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  75. Prediction of incident atrial fibrillation using deep learning, clinical models, and polygenic scores

    Article • European Heart Journal, September 2024, Oxford University Press (OUP)

    Marie-Pierre Dubé

  76. A Genome-Wide Association Study of Oxypurinol Concentrations in Patients Treated with Allopurinol

    Article • Journal of Personalized Medicine, June 2024, MDPI AG

    Marie-Pierre Dubé

  77. Meta-Analysis of Genome-Wide Association Studies Reveals Genetic Mechanisms of Supraventricular Arrhythmias

    Article • Circulation Genomic and Precision Medicine, June 2024, Wolters Kluwer Health

    Dr Habib Khan, Marie-Pierre Dubé

  78. Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  79. Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  80. Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  81. Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  82. Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  83. Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  84. Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  85. Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  86. Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  87. Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  88. Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  89. Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  90. Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  91. Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  92. Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  93. Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  94. Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  95. Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  96. Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  97. Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  98. Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  99. Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  100. Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  101. Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  102. Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  103. Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  104. Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  105. Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  106. Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  107. Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  108. Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  109. Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  110. Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  111. Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  112. Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  113. Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  114. Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  115. Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • May 2024, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  116. A Genomewide Association Study of Oxypurinol Concentrations in Patients Treated with Allopurinol

    Article • May 2024, MDPI AG

    Marie-Pierre Dubé

  117. Childhood Maltreatment and Leukocyte Telomere Length: Cardiac Vagal Activity Influences the Relation in Older Adults

    Article • Psychosomatic Medicine, February 2024, Wolters Kluwer Health

    Marie-Pierre Dubé

  118. A dataset of proteomic changes during human heat stress and heat acclimation

    Article • Scientific Data, December 2023, Springer Science + Business Media

    Marie-Pierre Dubé

  119. Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  120. Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  121. Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  122. Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  123. Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  124. Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  125. Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  126. Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  127. Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  128. Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  129. Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  130. Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  131. Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  132. Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  133. Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  134. Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  135. Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  136. Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  137. Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  138. Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  139. Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  140. Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  141. Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  142. Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  143. Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  144. Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  145. Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  146. Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  147. Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  148. Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  149. Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  150. Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  151. Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  152. Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  153. Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  154. Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  155. Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • November 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  156. T46. DO SEX AND GENDER MODIFY THE EFFECT OF APOE-Ɛ4 ON NEUROCOGNITIVE IMPAIRMENT? A MULTI-ANCESTRY ANALYSIS IN THE UK BIOBANK

    Article • European Neuropsychopharmacology, October 2023, Elsevier

    Marie-Pierre Dubé

  157. Impact of amiodarone use on metoprolol concentrations, α‐OH‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study

    Article • Pharmacology Research & Perspectives, September 2023, Wiley

    Marie-Pierre Dubé

  158. Assessing the role of rare pathogenic variants in heart failure progression by exome sequencing in 8,089 patients

    Article • August 2023, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  159. The Influence of Illness Perception and Coping on Anxiety in Adults With Congenital Heart Disease

    Article • JACC Advances, August 2023, Elsevier

    Marie-Pierre Dubé

  160. Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals

    Article • Blood Advances, July 2023, American Society of Hematology

    Marie-Pierre Dubé

  161. Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  162. Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  163. Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  164. Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  165. Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  166. Figure 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  167. Figure 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  168. Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  169. Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  170. Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  171. Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  172. Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  173. Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  174. Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  175. Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  176. Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  177. Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  178. Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  179. Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  180. Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  181. Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  182. Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  183. Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  184. Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  185. Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  186. Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  187. Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  188. Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  189. Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  190. Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  191. Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  192. Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  193. Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  194. Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  195. Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  196. Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  197. Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  198. Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  199. Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  200. Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  201. Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  202. Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  203. Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  204. Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  205. Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • June 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  206. Pharmacogenomic Markers of Metoprolol and α-OH-Metoprolol Concentrations: A Genome-Wide Association Study

    Article • Pharmacogenomics, June 2023, Taylor & Francis

    Marie-Pierre Dubé

  207. Data from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  208. Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  209. Supplementary Figure 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  210. Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  211. Supplementary Figure 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  212. Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  213. Supplementary Table 1 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  214. Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  215. Supplementary Table 10 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  216. Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  217. Supplementary Table 11 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  218. Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  219. Supplementary Table 12 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  220. Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  221. Supplementary Table 13 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  222. Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  223. Supplementary Table 14 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  224. Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  225. Supplementary Table 15 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  226. Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  227. Supplementary Table 16 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  228. Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  229. Supplementary Table 2 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  230. Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  231. Supplementary Table 3 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  232. Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  233. Supplementary Table 4 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  234. Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  235. Supplementary Table 5 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  236. Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  237. Supplementary Table 6 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  238. Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  239. Supplementary Table 7 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  240. Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  241. Supplementary Table 8 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  242. Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  243. Supplementary Table 9 from Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • April 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  244. Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors

    Article • Cancer Epidemiology Biomarkers & Prevention, March 2023, American Association for Cancer Research (AACR)

    Marie-Pierre Dubé

  245. Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males

    Article • Clinical and Translational Science, March 2023, Wiley

    Marie-Pierre Dubé

  246. Study of effect modifiers of genetically predicted CETP reduction

    Article • Genetic Epidemiology, January 2023, Wiley

    Marie-Pierre Dubé

  247. Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2023, New England Journal of Medicine (NEJM/MMS)

    Marie-Pierre Dubé

  248. Childhood maltreatment and leukocyte telomere length in men and women with chronic illness: an evaluation of moderating and mediating influences

    Article • Psychological Medicine, November 2022, Cambridge University Press

    Marie-Pierre Dubé

  249. Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome

    Article • European Heart Journal, November 2022, Oxford University Press (OUP)

    Marie-Pierre Dubé

  250. Abstract 10075: Hematopoietic Mosaic Chromosomal Alterations and Cardiovascular Disease-Related Deaths Among Cancer Survivors: An Analysis of the UK Biobank

    Article • Circulation, November 2022, Wolters Kluwer Health

    Marie-Pierre Dubé

  251. Erratum to: Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial

    Article • European Heart Journal, September 2022, Oxford University Press (OUP)

    Marie-Pierre Dubé

  252. Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies

    Article • International Journal of Cardiology, September 2022, Elsevier

    Marie-Pierre Dubé

  253. Do variants in the coding regions of FOXP2, a gene implicated in speech disorder, confer a risk for congenital amusia?

    Article • Annals of the New York Academy of Sciences, August 2022, Wiley

    Marie-Pierre Dubé

  254. Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial

    Article • European Heart Journal, July 2022, Oxford University Press (OUP)

    Marie-Pierre Dubé

  255. Including diverse and admixed populations in genetic epidemiology research

    Article • Genetic Epidemiology, July 2022, Wiley

    Marie-Pierre Dubé

  256. Pharmacogenomic study of heart failure and candesartan response from the CHARM programme

    Article • ESC Heart Failure, June 2022, Wiley

    Marie-Pierre Dubé

  257. An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites

    Article • Clinical and Translational Science, June 2022, Wiley

    Marie-Pierre Dubé

  258. Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease

    Article • Nature Communications, June 2022, Springer Science + Business Media

    Marie-Pierre Dubé

  259. Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signalling involved in atheroprotection

    Article • Cardiovascular Research, May 2022, Oxford University Press (OUP)

    Marie-Pierre Dubé

  260. ExPheWas: a platform for cis -Mendelian randomization and gene-based association scans

    Article • Nucleic Acids Research, April 2022, Oxford University Press (OUP)

    Marie-Pierre Dubé

  261. Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19

    Article • International Journal of Infectious Diseases, March 2022, Elsevier

    Marie-Pierre Dubé

  262. Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study

    Article • Clinical and Translational Science, February 2022, Wiley

    Marie-Pierre Dubé

  263. Gender matters in heart attack prevention: higher femininity linked to angina diagnosis in men

    Article • Scientific Reports, February 2022, Springer Science + Business Media

    Marie-Pierre Dubé

  264. Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation

    Article • Frontiers in Pharmacology, January 2022, Frontiers

    Marie-Pierre Dubé

  265. Quantitative Trait of Neutrophil Count Is Influenced By Variants in the Region of Gsdma and PSMD3-CSF3, aging, Cardiometabolic Comorbidities but Not By Chip

    Article • Blood, November 2021, American Society of Hematology

    Marie-Pierre Dubé

  266. Study of effect modifiers of genetically predicted CETP reduction

    Article • October 2021, Springer Science + Business Media

    Marie-Pierre Dubé

  267. A sex-specific evolutionary interaction between ADCY9 and CETP

    Article • eLife, October 2021, eLife

    Marie-Pierre Dubé

  268. Pharmacogenomic study of heart failure and candesartan response from the CHARM programme

    Article • September 2021, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  269. Study of effect modifiers of genetically predicted CETP reduction

    Article • September 2021, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  270. Author response: A sex-specific evolutionary interaction between ADCY9 and CETP

    Article • September 2021, eLife

    Marie-Pierre Dubé

  271. The genomics of heart failure: design and rationale of the HERMES consortium

    Article • ESC Heart Failure, September 2021, Wiley

    Professor John GF Cleland, Marie-Pierre Dubé

  272. Multitrait GWAS to connect disease variants and biological mechanisms

    Article • PLoS Genetics, August 2021, PLOS

    Marie-Pierre Dubé

  273. Comprehensive genetic analysis of the human lipidome identifies novel loci controlling lipid homeostasis with links to coronary artery disease

    Article • August 2021, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  274. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

    Article • The Lancet Respiratory Medicine, August 2021, Elsevier

    Marie-Pierre Dubé

  275. Genetics of symptom remission in outpatients with COVID-19

    Article • Scientific Reports, May 2021, Springer Science + Business Media

    Marie-Pierre Dubé

  276. A sex-specific evolutionary interaction betweenADCY9andCETP

    Article • May 2021, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  277. Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

    Article • Canadian Journal of Cardiology, May 2021, Elsevier

    Marie-Pierre Dubé

  278. Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT

    Article • Circulation Genomic and Precision Medicine, April 2021, Wolters Kluwer Health

    Marie-Pierre Dubé

  279. Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib

    Article • Circulation Genomic and Precision Medicine, April 2021, Wolters Kluwer Health

    Marie-Pierre Dubé

  280. Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

    Article • European Heart Journal, March 2021, Oxford University Press (OUP)

    Marie-Pierre Dubé

  281. ExPheWas: a browser for gene-based pheWAS associations

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  282. Genetics of symptom remission in outpatients with COVID-19

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  283. Genetic meta-analysis of cancer diagnosis following statin use identifies new associations and implicates human leukocyte antigen (HLA) in women

    Article • The Pharmacogenomics Journal, March 2021, Springer Science + Business Media

    Marie-Pierre Dubé

  284. Comparative effectiveness and safety of high‐dose rivaroxaban and apixaban for atrial fibrillation: A propensity score‐matched cohort study

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, February 2021, Wiley

    Marie-Pierre Dubé

  285. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect

    Article • Nature Genetics, January 2021, Springer Science + Business Media

    Marie-Pierre Dubé

  286. The associations of hostility and defensiveness with telomere length are influenced by sex and health status

    Article • Biology of Sex Differences, January 2021, Springer Science + Business Media

    Marie-Pierre Dubé

  287. A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy

    Article • ESC Heart Failure, September 2020, Wiley

    Marie-Pierre Dubé

  288. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

    Article • European Heart Journal, August 2020, Oxford University Press (OUP)

    Marie-Pierre Dubé

  289. Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure

    Article • Clinical and Translational Science, August 2020, Wiley

    Marie-Pierre Dubé

  290. Statin Initiation: Guideline Concordance and Characteristics of New Users in Quebec, Canada

    Article • Journal of Population Therapeutics and Clinical Pharmacology, August 2020, Codon Publications

    Marie-Pierre Dubé

  291. A genetic model of ivabradine recapitulates results from randomized clinical trials

    Article • PLOS One, July 2020, PLOS

    Marie-Pierre Dubé

  292. Multitrait genetic-phenotype associations to connect disease variants and biological mechanisms

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  293. High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential

    Article • Blood Advances, June 2020, American Society of Hematology

    Marie-Pierre Dubé

  294. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, May 2020, Oxford University Press (OUP)

    Marie-Pierre Dubé

  295. CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta‐analysis

    Article • British Journal of Clinical Pharmacology, April 2020, Wiley

    Marie-Pierre Dubé

  296. Heritability of 596 lipid species and genetic correlation with cardiovascular traits in the Busselton Family Heart Study

    Article • Journal of Lipid Research, April 2020, Elsevier

    Marie-Pierre Dubé

  297. Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA‐HF trial

    Article • European Journal of Heart Failure, April 2020, Wiley

    Marie-Pierre Dubé

  298. Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib

    Article • American Heart Journal, April 2020, Elsevier

    Marie-Pierre Dubé

  299. A genetic model of ivabradine recapitulates results from randomized clinical trials

    Article • February 2020, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  300. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2019, New England Journal of Medicine (NEJM/MMS)

    Marie-Pierre Dubé

  301. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, December 2019, Wiley

    Marie-Pierre Dubé

  302. Inherited Chromosomally Integrated Human Herpesvirus 6 Demonstrates Tissue-Specific RNA Expression In Vivo That Correlates with an Increased Antibody Immune Response

    Article • Journal of Virology, December 2019, ASM Journals

    Marie-Pierre Dubé

  303. Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes

    Article • The American Journal of Cardiology, December 2019, Elsevier

    Marie-Pierre Dubé

  304. rs73185306 C/T Is Not a Predisposing Risk Factor for Inherited Chromosomally Integrated Human Herpesvirus 6A/B

    Article • The Journal of Infectious Diseases, October 2019, Oxford University Press (OUP)

    Marie-Pierre Dubé

  305. Inherited chromosomally integrated HHV-6 demonstrates tissue-specific RNA expressionin vivothat correlates with increased antibody immune response

    Article • August 2019, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  306. Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

    Article • Nature Genetics, June 2019, Springer Science + Business Media

    Marie-Pierre Dubé

  307. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians

    Article • Circulation Genomic and Precision Medicine, June 2019, Wolters Kluwer Health

    Marie-Pierre Dubé

  308. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

    Article • Circulation Genomic and Precision Medicine, April 2019, Wolters Kluwer Health

    Professor Marek Sanak, Marie-Pierre Dubé

  309. Subsequent Event Risk in Individuals With Established Coronary Heart Disease

    Article • Circulation Genomic and Precision Medicine, April 2019, Wolters Kluwer Health

    Professor Marek Sanak, Marie-Pierre Dubé

  310. Lipoprotein (a), arterial inflammation, and PCSK9 inhibition

    Article • European Heart Journal, March 2019, Oxford University Press (OUP)

    Marie-Pierre Dubé

  311. LONG-TERM RESIDUAL RISK AND PREDICTORS OF CARDIOVASCULAR DISEASE IN INDIVIDUALS TAKING STATINS FOR PRIMARY PREVENTION: INSIGHTS FROM THE CARTAGENE STUDY

    Article • Journal of the American College of Cardiology, March 2019, Elsevier

    Marie-Pierre Dubé

  312. Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution

    Article • Nature Genetics, February 2019, Springer Science + Business Media

    Marie-Pierre Dubé

  313. Validation of genome-wide polygenic risk scores for coronary artery disease in French Canadians

    Article • February 2019, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  314. Biomarkers of dementia in obstructive sleep apnea

    Article • Sleep Medicine Reviews, December 2018, Elsevier

    Marie-Pierre Dubé

  315. ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein)

    Article • Circulation, October 2018, Wolters Kluwer Health

    Marie-Pierre Dubé

  316. Pharmacogenetic content of commercial genome-wide genotyping arrays

    Article • Pharmacogenomics, October 2018, Future Medicine

    Marie-Pierre Dubé

  317. Randomized Clinical Trial Needed to Confirm Whether Dalcetrapib Improves Outcomes for Specific ADCY9 Genotype

    Article • JAMA Cardiology, September 2018, American Medical Association (AMA)

    Marie-Pierre Dubé

  318. Variants at the APOE/C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol

    Article • Journal of the American Heart Association, August 2018, Wolters Kluwer Health

    Marie-Pierre Dubé

  319. Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A

    Article • Blood, July 2018, American Society of Hematology

    Marie-Pierre Dubé

  320. Protein-Coding Variants Implicate Novel Genes Related to Lipid Homeostasis Contributing to Body Fat Distribution

    Article • June 2018, Cold Spring Harbor Laboratory Press

    Marie-Pierre Dubé

  321. Sex, drugs, and heart failure: a sex-sensitive review of the evidence base behind current heart failure clinical guidelines

    Article • ESC Heart Failure, June 2018, Wiley

    Marie-Pierre Dubé

  322. Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study

    Article • Clinical Cardiology, May 2018, Wiley

    Marie-Pierre Dubé

  323. A Discrete Event Simulation Model For A Pharmacogenomics Test For Statin-Induced Myopathy In Patients Initiating A Statin In Secondary Cardiovascular Prevention

    Article • Value in Health, May 2018, Elsevier

    Marie-Pierre Dubé

  324. Abstract 624: Interactions Between Adenylate Cyclase Type 9 (ADCY9) and Cholesteryl Ester Transfer Protein (CETP) in Atherosclerosis

    Article • Arteriosclerosis Thrombosis and Vascular Biology, May 2018, Wolters Kluwer Health

    Marie-Pierre Dubé

  325. Pharmacogenomics of blood lipid regulation

    Article • Pharmacogenomics, April 2018, Future Medicine

    Marie-Pierre Dubé

  326. A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure

    Article • Pharmacogenomics, April 2018, Future Medicine

    Marie-Pierre Dubé

  327. A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention

    Article • Molecular Diagnosis & Therapy, April 2018, Springer Science + Business Media

    Marie-Pierre Dubé

  328. Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

    Article • Nature Genetics, March 2018, Springer Science + Business Media

    Marie-Pierre Dubé

  329. Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

    Article • Nature Genetics, March 2018, Springer Science + Business Media

    Marie-Pierre Dubé

  330. Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort

    Article • The Pharmacogenomics Journal, January 2018, Springer Science + Business Media

    Marie-Pierre Dubé

  331. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

    Article • Nature Genetics, December 2017, Springer Science + Business Media

    Professor Trevor A Mori, Giovanni Veronesi, Marie-Pierre Dubé

  332. Polygenic determinants in extremes of high-density lipoprotein cholesterol

    Article • Journal of Lipid Research, November 2017, Elsevier

    Marie-Pierre Dubé

  333. ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol Levels

    Article • Arteriosclerosis Thrombosis and Vascular Biology, November 2017, Wolters Kluwer Health

    Marie-Pierre Dubé

  334. Exome-wide association study of plasma lipids in >300,000 individuals

    Article • Nature Genetics, October 2017, Springer Science + Business Media

    Marie-Pierre Dubé

  335. Precision medicine to change the landscape of cardiovascular drug development

    Article • Expert Review of Precision Medicine and Drug Development, October 2017, Taylor & Francis

    Marie-Pierre Dubé

  336. Impact of Selection Bias on Estimation of Subsequent Event Risk

    Article • Circulation Cardiovascular Genetics, October 2017, Wolters Kluwer Health

    Marie-Pierre Dubé

  337. Identification of the genetic determinants responsible for retinal degeneration in families of Mexican descent

    Article • Ophthalmic Genetics, September 2017, Taylor & Francis

    Marie-Pierre Dubé

  338. Pharmacogenetics of Lipid-Lowering Agents: an Update Review on Genotype-Dependent Effects of HDL-Targetingand Statin Therapies

    Article • Current Atherosclerosis Reports, September 2017, Springer Science + Business Media

    Marie-Pierre Dubé

  339. DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions

    Article • Blood, August 2017, American Society of Hematology

    Marie-Pierre Dubé

  340. CKing Precision in the Interpretation of Diagnostic Biomarkers

    Article • Circulation Cardiovascular Genetics, August 2017, Wolters Kluwer Health

    Marie-Pierre Dubé

  341. Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based Studies

    Article • JMIR Research Protocols, May 2017, JMIR Publications Inc.

    Marie-Pierre Dubé

  342. Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve

    Article • Nature Communications, May 2017, Springer Science + Business Media

    Marie-Pierre Dubé

  343. CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction

    Article • The Pharmacogenomics Journal, April 2017, Springer Science + Business Media

    Marie-Pierre Dubé

  344. Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrol

    Article • PLOS One, April 2017, PLOS

    Marie-Pierre Dubé

  345. CETP

    Article • Arteriosclerosis Thrombosis and Vascular Biology, March 2017, Wolters Kluwer Health

    Marie-Pierre Dubé

  346. Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease

    Article • Journal of the American College of Cardiology, February 2017, Elsevier

    Marie-Pierre Dubé

  347. Whole Exome Sequencing of Affected Individuals From Large Consanguineous Pedigrees With Psychotic/Affective Disorders From Pakistan

    Article • European Neuropsychopharmacology, January 2017, Elsevier

    Marie-Pierre Dubé

  348. Pharmacogenomic approaches to lipid-regulating trials

    Article • Current Opinion in Lipidology, December 2016, Wolters Kluwer Health

    Marie-Pierre Dubé

  349. Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically

    Article • Arteriosclerosis Thrombosis and Vascular Biology, December 2016, Wolters Kluwer Health

    Marie-Pierre Dubé

  350. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality

    Article • Pharmacoepidemiology and Drug Safety, November 2016, Wiley

    Marie-Pierre Dubé

  351. Risk of Mortality and Hospital Readmission Among Older Adults with Heart Failure Treated with Carvedilol, Bisoprolol or Metoprolol Tartrate

    Article • Value in Health, November 2016, Elsevier

    Marie-Pierre Dubé

  352. Paternal Age Explains a Major Portion of De Novo Germline Mutation Rate Variability in Healthy Individuals

    Article • PLOS One, October 2016, PLOS

    Marie-Pierre Dubé

  353. A model to assess the cost–effectiveness of pharmacogenomics tests in chronic heart failure: the case of ivabradine

    Article • Pharmacogenomics, October 2016, Future Medicine

    Marie-Pierre Dubé

  354. Maximal expected benefits from lowering cholesterol in primary prevention for a high-risk population

    Article • Current Medical Research and Opinion, September 2016, Taylor & Francis

    Marie-Pierre Dubé

  355. Meta-analysis of genome-wide association studies of HDL cholesterol response to statins

    Article • Journal of Medical Genetics, September 2016, BMJ

    Marie-Pierre Dubé

  356. genipe: an automated genome-wide imputation pipeline with automatic reporting and statistical tools

    Article • Bioinformatics, August 2016, Oxford University Press (OUP)

    Marie-Pierre Dubé

  357. Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation

    Article • Circulation Cardiovascular Genetics, August 2016, Wolters Kluwer Health

    Marie-Pierre Dubé

  358. CYP3A4 Genotype is Associated with Sildenafil Concentrations in Patients with Heart Failure with Preserved Ejection Fraction

    Article • Journal of Cardiac Failure, August 2016, Elsevier

    Marie-Pierre Dubé

  359. Whole-genome sequencing in French Canadians from Quebec

    Article • Human Genetics, July 2016, Springer Science + Business Media

    Marie-Pierre Dubé

  360. Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits

    Article • The American Journal of Human Genetics, July 2016, Elsevier

    Marie-Pierre Dubé

  361. Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals

    Article • The American Journal of Human Genetics, July 2016, Elsevier

    Marie-Pierre Dubé

  362. DNA methylation signature of human fetal alcohol spectrum disorder

    Article • Epigenetics & Chromatin, June 2016, Springer Science + Business Media

    Marie-Pierre Dubé

  363. Avoidance of Vitamin K−Rich Foods Is Common among Warfarin Users and Translates into Lower Usual Vitamin K Intakes

    Article • Journal of the Academy of Nutrition and Dietetics, June 2016, Elsevier

    Marie-Pierre Dubé

  364. Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users

    Article • Journal of Managed Care & Specialty Pharmacy, June 2016, Academy of Managed Care Pharmacy

    Marie-Pierre Dubé

  365. Methylomic changes during conversion to psychosis

    Article • Molecular Psychiatry, April 2016, Springer Science + Business Media

    Marie-Pierre Dubé

  366. Coding Variation inANGPTL4,LPL,andSVEP1and the Risk of Coronary Disease

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2016, New England Journal of Medicine (NEJM/MMS)

    Marie-Pierre Dubé

  367. A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials

    Article • The Pharmacogenomics Journal, March 2016, Springer Science + Business Media

    Marie-Pierre Dubé

  368. An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance

    Article • Thrombosis and Haemostasis, March 2016, Thieme Publishing Group

    Marie-Pierre Dubé

  369. Testing the role of predicted gene knockouts in human anthropometric trait variation

    Article • Human Molecular Genetics, February 2016, Oxford University Press (OUP)

    Marie-Pierre Dubé

  370. Resting heart rate as a predictor of aortic valve stenosis progression

    Article • International Journal of Cardiology, February 2016, Elsevier

    Marie-Pierre Dubé

  371. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease

    Article • Cardiovascular Drugs and Therapy, January 2016, Springer Science + Business Media

    Marie-Pierre Dubé

  372. Calcium Signaling Pathway GenesRUNX2andCACNA1CAre Associated With Calcific Aortic Valve DiseaseCLINICAL PERSPECTIVE

    Article • Circulation Cardiovascular Genetics, November 2015, Wolters Kluwer Health

    Dr Sandra Guauque-Olarte, Marie-Pierre Dubé

  373. ISDN2014_0418: DNA methylation changes in fetal alcohol spectrum disorder

    Article • International Journal of Developmental Neuroscience, November 2015, Wiley

    Marie-Pierre Dubé

  374. Association of Treatment with Carvedilol, Bisoprolol and Metoprolol on the Risk of Mortality and Hospital Admission Among Older Adults with Heart Failure

    Article • Value in Health, November 2015, Elsevier

    Dr Benjamin Haibe-Kains, Marie-Pierre Dubé

  375. Impact of Genetic Factors on Gastrointestinal Bleeding in a Prospective Cohort of new Warfarin users

    Article • Value in Health, November 2015, Elsevier

    Marie-Pierre Dubé

  376. Will personalized drugs for cardiovascular disease become an option? – Defining ‘Evidence-based personalized medicine’ for its implementation and future use

    Article • Expert Opinion on Pharmacotherapy, September 2015, Informa Healthcare

    Marie-Pierre Dubé

  377. Impact of regular physical activity on weekly warfarin dose requirement

    Article • Journal of Thrombosis and Thrombolysis, August 2015, Springer Science + Business Media

    Marie-Pierre Dubé

  378. A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials

    Article • Journal of Cardiac Failure, August 2015, Elsevier

    Marie-Pierre Dubé

  379. Mutation Burden of Rare Variants in Schizophrenia Candidate Genes

    Article • PLOS One, June 2015, PLOS

    Marie-Pierre Dubé

  380. Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review

    Article • Pharmacogenomics, May 2015, Future Medicine

    Marie-Pierre Dubé

  381. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice

    Article • International Journal of Cardiology, April 2015, Elsevier

    Marie-Pierre Dubé

  382. Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

    Article • Circulation Cardiovascular Genetics, April 2015, Wolters Kluwer Health

    Marie-Pierre Dubé

  383. Comparison of Sequencing Based CNV Discovery Methods Using Monozygotic Twin Quartets

    Article • PLOS One, March 2015, PLOS

    Marie-Pierre Dubé

  384. CKM and LILRB5 Are Associated With Serum Levels of Creatine Kinase

    Article • Circulation Cardiovascular Genetics, December 2014, Wolters Kluwer Health

    Marie-Pierre Dubé

  385. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

    Article • Nature Communications, October 2014, Springer Science + Business Media

    Professor Janusz Antoni Jankowski, Marie-Pierre Dubé

  386. G.P.197

    Article • Neuromuscular Disorders, October 2014, Elsevier

    Marie-Pierre Dubé

  387. Genetic Markers of Cisplatin-Induced Hearing Loss in Children

    Article • Clinical Pharmacology & Therapeutics, September 2014, Springer Science + Business Media

    Marie-Pierre Dubé

  388. Modifiers of (CAG)n instability in Machado–Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes

    Article • Human Genetics, July 2014, Springer Science + Business Media

    Jorge Sequeiros, Marie-Pierre Dubé

  389. Development of a broad-based ADME panel for use in pharmacogenomic studies

    Article • Pharmacogenomics, July 2014, Future Medicine

    Marie-Pierre Dubé

  390. Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis

    Article • Circulation Cardiovascular Genetics, June 2014, Wolters Kluwer Health

    Marie-Pierre Dubé

  391. Novel presenilin mutations within Moroccan patients with Early-Onset Alzheimer’s Disease

    Article • Neuroscience, June 2014, Elsevier

    Marie-Pierre Dubé

  392. The Use Of Pillbox And Time In Therapeutic Range Among New Users Of Warfarin: A Propective Cohort Study

    Article • Value in Health, May 2014, Elsevier

    Marie-Pierre Dubé

  393. Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits

    Article • Nature Genetics, April 2014, Springer Science + Business Media

    Marie-Pierre Dubé

  394. Novel Mutations in the Amyloid Precursor Protein Gene within Moroccan Patients with Alzheimer's Disease

    Article • Journal of Molecular Neuroscience, March 2014, Springer Science + Business Media

    Marie-Pierre Dubé

  395. Comparison of genotype clustering tools with rare variants

    Article • BMC Bioinformatics, February 2014, Springer Science + Business Media

    Marie-Pierre Dubé

  396. Cuckoo search epistasis: a new method for exploring significant genetic interactions

    Article • Heredity, February 2014, Springer Science + Business Media

    Marie-Pierre Dubé

  397. Validation of patient-reported warfarin dose in a prospective incident cohort study

    Article • Pharmacoepidemiology and Drug Safety, January 2014, Wiley

    Marie-Pierre Dubé

  398. Evaluation of Links Between High-Density Lipoprotein Genetics, Functionality, and Aortic Valve Stenosis Risk in Humans

    Article • Arteriosclerosis Thrombosis and Vascular Biology, December 2013, Wolters Kluwer Health

    Dr Sandra Guauque-Olarte, Marie-Pierre Dubé

  399. Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity

    Article • Clinical Pharmacology & Therapeutics, November 2013, Springer Science + Business Media

    Marie-Pierre Dubé

  400. Validity of Self-Reported Dose of Patients Using Wafarin in Clinical Practice

    Article • Value in Health, November 2013, Elsevier

    Marie-Pierre Dubé

  401. Lipoprotein(a) levels, genotype and incident aortic stenosis: a prospective Mendelian randomization study and replication in a case-control cohort

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Marie-Pierre Dubé

  402. pyGenClean: efficient tool for genetic data clean up before association testing

    Article • Bioinformatics, May 2013, Oxford University Press (OUP)

    Marie-Pierre Dubé

  403. Erratum: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

    Article • Nature Genetics, April 2013, Springer Science + Business Media

    Marie-Pierre Dubé

  404. Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent

    Article • The Pharmacogenomics Journal, April 2013, Springer Science + Business Media

    Marie-Pierre Dubé

  405. Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children

    Article • Clinical Pharmacology & Therapeutics, April 2013, Springer Science + Business Media

    Marie-Pierre Dubé

  406. The Impact of Partial and Complete Loss-of-Function Mutations in Endothelial Lipase on High-Density Lipoprotein Levels and Functionality in Humans

    Article • Circulation Cardiovascular Genetics, February 2013, Wolters Kluwer Health

    Marie-Pierre Dubé

  407. Institutional Profile: The Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre at the Montreal Heart Institute

    Article • Pharmacogenomics, January 2013, Future Medicine

    Marie-Pierre Dubé

  408. SRAP Polymorphisms Associated to Cell Wall Degradability in Lignified Stems of Alfalfa

    Article • BioEnergy Research, December 2012, Springer Science + Business Media

    Marie-Pierre Dubé

  409. Characterization of two novel cold-inducible K3 dehydrin genes from alfalfa (Medicago sativa spp. sativa L.)

    Article • Theoretical and Applied Genetics, November 2012, Springer Science + Business Media

    Marie-Pierre Dubé

  410. Pooled DNA Resequencing of 68 Myocardial Infarction Candidate Genes in French Canadians

    Article • Circulation Cardiovascular Genetics, October 2012, Wolters Kluwer Health

    Marie-Pierre Dubé

  411. G.P.126 “Strongman syndrome”: A new autosomal dominant herculean painful myopathy

    Article • Neuromuscular Disorders, October 2012, Elsevier

    Marie-Pierre Dubé

  412. Rare Copy Number Variants Contribute to Congenital Left-Sided Heart Disease

    Article • PLoS Genetics, September 2012, PLOS

    Marie-Pierre Dubé

  413. Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice

    Article • Physiological Genomics, September 2012, American Physiological Society

    Marie-Pierre Dubé

  414. Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol

    Article • PLOS One, August 2012, PLOS

    Marie-Pierre Dubé

  415. Assessment of Genetic Variability of Cell Wall Degradability for the Selection of Alfalfa with Improved Saccharification Efficiency

    Article • BioEnergy Research, May 2012, Springer Science + Business Media

    Marie-Pierre Dubé

  416. PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients

    Article • Pharmacogenetics and Genomics, May 2012, Wolters Kluwer Health

    Marie-Pierre Dubé

  417. Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

    Article • Journal of Clinical Oncology, May 2012, American Society of Clinical Oncology (ASCO)

    Marie-Pierre Dubé

  418. Molecular physiology and breeding at the crossroads of cold hardiness improvement

    Article • Physiologia Plantarum, April 2012, Wiley

    Marie-Pierre Dubé

  419. Risk of congenital heart defects is influenced by genetic variation in folate metabolism

    Article • Cardiology in the Young, April 2012, Cambridge University Press

    Marie-Pierre Dubé

  420. A Novel PLP1 Mutation Further Expands the Clinical Heterogeneity at the Locus

    Article • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, March 2012, Cambridge University Press

    Marie-Pierre Dubé

  421. Erratum to: Intron-length polymorphism identifies a Y2K4 dehydrin variant linked to superior freezing tolerance in alfalfa

    Article • Theoretical and Applied Genetics, February 2012, Springer Science + Business Media

    Marie-Pierre Dubé

  422. Validation of warfarin pharmacogenetic algorithms in clinical practice

    Article • Pharmacogenomics, January 2012, Future Medicine

    Marie-Pierre Dubé

  423. Tacrolimus-induced nephrotoxicity and genetic variability: A review

    Article • Annals of Transplantation, January 2012, International Scientific Literature

    Marie-Pierre Dubé

  424. Intron-length polymorphism identifies a Y2K4 dehydrin variant linked to superior freezing tolerance in alfalfa

    Article • Theoretical and Applied Genetics, November 2011, Springer Science + Business Media

    Marie-Pierre Dubé

  425. Design and rationale of a genetic cohort study on congenital cardiac disease: experiences from a multi-institutional platform in Quebec

    Article • Cardiology in the Young, July 2011, Cambridge University Press

    Marie-Pierre Dubé

  426. Predicting Statin Induced Muscle Toxicity

    Article • Journal of Clinical Lipidology, May 2011, Elsevier

    Marie-Pierre Dubé

  427. Fetal Alcohol Spectrum Disorders: Gene-Environment Interactions, Predictive Biomarkers, and the Relationship Between Structural Alterations in the Brain and Functional Outcomes

    Article • Seminars in Pediatric Neurology, March 2011, Elsevier

    Marie-Pierre Dubé

  428. Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors

    Article • The Journal of Heart and Lung Transplantation, March 2011, Elsevier

    Marie-Pierre Dubé

  429. Familial ventricular aneurysms and septal defects map to chromosome 10p15

    Article • European Heart Journal, December 2010, European Society of Cardiology

    Marie-Pierre Dubé

  430. Positional cloning of a quantitative trait locus contributing to pain sensitivity: possible mediation by Tyrp1

    Article • Genes Brain & Behavior, November 2010, Wiley

    Marie-Pierre Dubé

  431. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura

    Article • Nature Reports Stem Cells, September 2010, Nature

    Jorge Sequeiros, Marie-Pierre Dubé

  432. Direct Measure of the De Novo Mutation Rate in Autism and Schizophrenia Cohorts

    Article • The American Journal of Human Genetics, September 2010, Elsevier

    Marie-Pierre Dubé

  433. Partitioning of copy-number genotypes in pedigrees

    Article • BMC Bioinformatics, May 2010, Springer Science + Business Media

    Marie-Pierre Dubé

  434. Family Study of Restless Legs Syndrome in Quebec, Canada

    Article • Archives of Neurology, May 2010, American Medical Association (AMA)

    Marie-Pierre Dubé

  435. Mutations in DCC Cause Congenital Mirror Movements

    Article • Science, April 2010, American Association for the Advancement of Science

    Marie-Pierre Dubé

  436. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia

    Article • Proceedings of the National Academy of Sciences, April 2010, Proceedings of the National Academy of Sciences

    Marie-Pierre Dubé

  437. Genetic determinants of blood pressure reduction following potassium supplementation: and the candidates are…

    Article • Journal of Hypertension, April 2010, Wolters Kluwer Health

    Marie-Pierre Dubé

  438. Genetics of bronchopulmonary dysplasia in the age of genomics

    Article • Current Opinion in Pediatrics, April 2010, Wolters Kluwer Health

    Marie-Pierre Dubé

  439. Testing for Gene-Gene Interaction with AMMI Models

    Article • Statistical Applications in Genetics and Molecular Biology, January 2010, De Gruyter

    Marie-Pierre Dubé

  440. Novel mutations in the sacsin gene in ataxia patients from Maritime Canada

    Article • Journal of the Neurological Sciences, January 2010, Elsevier

    Marie-Pierre Dubé

  441. Genome-Wide TDT Analysis in French-Canadian Families with Tourette Syndrome

    Article • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, January 2010, Cambridge University Press

    Marie-Pierre Dubé

  442. Genetic Studies

    Article • November 2009, Springer Science + Business Media

    Marie-Pierre Dubé

  443. Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

    Article • Nature Genetics, November 2009, Springer Science + Business Media

    Marie-Pierre Dubé

  444. Genetic Modulation of Brugada Syndrome by a Common Polymorphism

    Article • Journal of Cardiovascular Electrophysiology, October 2009, Wiley

    Marie-Pierre Dubé

  445. Application of principal component analysis to pharmacogenomic studies in Canada

    Article • The Pharmacogenomics Journal, August 2009, Springer Science + Business Media

    Marie-Pierre Dubé

  446. Association between cervical and intracranial dimensions and syringomyelia in the cavalier King Charles spaniel

    Article • Journal of Small Animal Practice, August 2009, Wiley

    Marie-Pierre Dubé

  447. Mutation in Pyrroline-5-Carboxylate Reductase 1 Gene in Families with Cutis Laxa Type 2

    Article • The American Journal of Human Genetics, July 2009, Elsevier

    Marie-Pierre Dubé

  448. Application of Homozygosity Haplotype Analysis to Genetic Mapping with High-Density SNP Genotype Data

    Article • PLOS One, April 2009, PLOS

    Marie-Pierre Dubé

  449. Genetic predictors of depressive symptoms in cardiac patients

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, April 2009, Wiley

    Marie-Pierre Dubé

  450. The challenge of detecting epistasis (G×G Interactions): Genetic Analysis Workshop 16

    Article • Genetic Epidemiology, January 2009, Wiley

    Marie-Pierre Dubé

  451. Autosomal-dominant locus for restless legs syndrome in French-Canadians on chromosome 16p12.1

    Article • Movement Disorders, October 2008, Wiley

    Marie-Pierre Dubé

  452. Génome Québec & Montreal Heart Institute Pharmacogenomics Centre: a translational pharmacogenomics platform – from R&D to the clinic

    Article • Pharmacogenomics, October 2008, Future Medicine

    Marie-Pierre Dubé

  453. Mutations in the calcium-related gene IL1RAPL1 are associated with autism

    Article • Human Molecular Genetics, September 2008, Oxford University Press (OUP)

    Marie-Pierre Dubé

  454. CYP3A5*1/*3 Genetic Polymorphism Is Associated with Post Cardiac Transplant Renal Dysfunction in Patients Treated with Calcineurin Inhibitors

    Article • Journal of Cardiac Failure, August 2008, Elsevier

    Marie-Pierre Dubé

  455. A survey of the personalized medicine landscape

    Article • Pharmacogenomics, July 2008, Future Medicine

    Marie-Pierre Dubé

  456. Effects of AGTR1 A1166C Gene Polymorphism in Patients with Heart Failure Treated with Candesartan

    Article • Annals of Pharmacotherapy, May 2008, SAGE Publications

    Marie-Pierre Dubé

  457. Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure

    Article • British Journal of Clinical Pharmacology, May 2008, Wiley

    Marie-Pierre Dubé

  458. A novel locus for idiopathic generalized epilepsy in French-Canadian families maps to 10p11

    Article • American Journal of Medical Genetics Part A, March 2008, Wiley

    Marie-Pierre Dubé

  459. No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans

    Article • Journal of Clinical Investigation, January 2008, American Society for Clinical Investigation

    Marie-Pierre Dubé

  460. The Genetics of Congenital Amusia (Tone Deafness): A Family-Aggregation Study

    Article • The American Journal of Human Genetics, September 2007, Elsevier

    Marie-Pierre Dubé

  461. Mutations in the UBIAD1 Gene, Encoding a Potential Prenyltransferase, Are Causal for Schnyder Crystalline Corneal Dystrophy

    Article • PLOS One, August 2007, PLOS

    Marie-Pierre Dubé

  462. Syringomyelia in cavalier King Charles spaniels: the relationship between syrinx dimensions and pain

    Article • Journal of Small Animal Practice, August 2007, Wiley

    Marie-Pierre Dubé

  463. Obesity and TCF7L2 variants' additive effect on type 2 diabetes risk in cardiac patients

    Article • Diabetes Care, June 2007, American Diabetes Association

    Marie-Pierre Dubé

  464. Molecular genetic studies of DMT1 on 12q in French‐Canadian restless legs syndrome patients and families

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, May 2007, Wiley

    Marie-Pierre Dubé

  465. Loss-of-function genetic diseases and the concept of pharmaceutical targets

    Article • Nature Reviews Genetics, May 2007, Springer Science + Business Media

    Marie-Pierre Dubé

  466. Gene-Gene Interaction Tests Using SVM and Neural Network Modeling

    Article • April 2007, Institute of Electrical & Electronics Engineers (IEEE)

    Marie-Pierre Dubé

  467. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations

    Article • Clinical Genetics, March 2007, Wiley

    Marie-Pierre Dubé

  468. Lamin A/C mutations associated with familial and sporadic cases of dilated cardiomyopathy in Koreans

    Article • Experimental & Molecular Medicine, February 2007, Springer Science + Business Media

    Marie-Pierre Dubé

  469. Multistage designs in the genomic era: Providing balance in complex disease studies

    Article • Genetic Epidemiology, January 2007, Wiley

    Marie-Pierre Dubé

  470. A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13

    Article • Neurology, September 2006, Wolters Kluwer Health

    Marie-Pierre Dubé

  471. Bootstrap Inference with Neural-Network Modeling for Gene-Disease Association Testing

    Article • September 2006, Institute of Electrical & Electronics Engineers (IEEE)

    Marie-Pierre Dubé

  472. A new locus for autosomal dominant intracranial aneurysm, ANIB4, maps to chromosome 5p15.2-14.3

    Article • Journal of Medical Genetics, June 2006, BMJ

    Marie-Pierre Dubé

  473. Human monogenic disorders — a source of novel drug targets

    Article • Nature Reviews Genetics, March 2006, Springer Science + Business Media

    Marie-Pierre Dubé

  474. Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin

    Article • Psychosomatic Medicine, March 2006, Wolters Kluwer Health

    Marie-Pierre Dubé

  475. Autism spectrum disorders associated with X chromosome markers in French-Canadian males

    Article • Molecular Psychiatry, November 2005, Springer Science + Business Media

    Marie-Pierre Dubé

  476. A Variant in XPNPEP2 Is Associated with Angioedema Induced by Angiotensin I–Converting Enzyme Inhibitors

    Article • The American Journal of Human Genetics, October 2005, Elsevier

    Marie-Pierre Dubé

  477. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, March 2005, Wiley

    Marie-Pierre Dubé

  478. Chromosome 11-q24 region in Tourette syndrome: Association and linkage disequilibrium study in the French Canadian population

    Article • American Journal of Medical Genetics Part A, January 2005, Wiley

    Marie-Pierre Dubé

  479. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease

    Article • Journal of the American College of Cardiology, October 2004, Elsevier

    Marie-Pierre Dubé

  480. The 14q restless legs syndrome locus in the French Canadian population

    Article • Annals of Neurology, May 2004, Wiley

    Marie-Pierre Dubé

  481. Identification of a Novel Gene (HSN2) Causing Hereditary Sensory and Autonomic Neuropathy Type II through the Study of Canadian Genetic Isolates

    Article • The American Journal of Human Genetics, May 2004, Elsevier

    Marie-Pierre Dubé

  482. Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis

    Article • Nature Genetics, November 2003, Springer Science + Business Media

    Marie-Pierre Dubé

  483. A Study of Discontinuing Maintenance Therapy in Human Immunodeficiency Virus–Infected Subjects with DisseminatedMycobacterium aviumComplex: AIDS Clinical Trial Group 393 Study Team

    Article • The Journal of Infectious Diseases, April 2003, Oxford University Press (OUP)

    Marie-Pierre Dubé

  484. Article • Cancer Causes & Control, January 2003, Springer Science + Business Media

    Marie-Pierre Dubé

  485. AnALS2gene mutation causes hereditary spastic paraplegia in a Pakistani kindred

    Article • Annals of Neurology, December 2002, Wiley

    Marie-Pierre Dubé

  486. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy

    Article • Nature Genetics, August 2002, Springer Science + Business Media

    Marie-Pierre Dubé

  487. Fine mapping the candidate region for peripheral neuropathy with or without agenesis of the corpus callosum in the French Canadian population

    Article • European Journal of Human Genetics, July 2002, Springer Science + Business Media

    Marie-Pierre Dubé

  488. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

    Article • Pharmacogenetics, October 2001, Wolters Kluwer Health

    Marie-Pierre Dubé

  489. Clouston hidrotic ectodermal dysplasia (HED): genetic homogeneity, presence of a founder effect in the French Canadian population and fine genetic mapping

    Article • European Journal of Human Genetics, May 2000, Springer Science + Business Media

    Marie-Pierre Dubé

  490. A Randomized Evaluation of Ethambutol for Prevention of Relapse and Drug Resistance during Treatment ofMycobacterium aviumComplex Bacteremia with Clarithromycin‐Based Combination Therapy

    Article • The Journal of Infectious Diseases, November 1997, Oxford University Press (OUP)

    Marie-Pierre Dubé

  491. Genomic structure of the human GT334 (EHOC-1) gene mapping to 21q22.3

    Article • Gene, October 1997, Elsevier

    Marie-Pierre Dubé

  492. Protease inhibitor-associated hyperglycaemia

    Article • The Lancet, September 1997, Elsevier

    Marie-Pierre Dubé

  493. Prophylaxis against DisseminatedMycobacterium aviumComplex with Weekly Azithromycin, Daily Rifabutin, or Both

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 1996, New England Journal of Medicine (NEJM/MMS)

    Marie-Pierre Dubé

  494. Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex Disease

    Article • Annals of Internal Medicine, December 1994, American College of Physicians

    Marie-Pierre Dubé

  495. Panculture Panned

    Article • JAMA, October 1993, American Medical Association (AMA)

    Marie-Pierre Dubé

  496. How Useful Are Cytomegalovirus Cultures in Patients with HIV Infection?

    Article • Annals of Internal Medicine, August 1993, American College of Physicians

    Marie-Pierre Dubé

  497. Prevention and treatment of opportunistic infections

    Article • Current Opinion in Infectious Diseases, April 1993, Wolters Kluwer Health

    Marie-Pierre Dubé

  498. Tuberculous meningitis in patients with and without human immunodeficiency virus infection

    Article • The American Journal of Medicine, November 1992, Elsevier

    Marie-Pierre Dubé